These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3500430)

  • 21. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 22. [Miocamycin: microbiological features].
    Renzini G; Scazzocchio F; Selan L
    Ann Ist Super Sanita; 1987; 23(4):883-6. PubMed ID: 3502551
    [No Abstract]   [Full Text] [Related]  

  • 23. The international experience with teicoplanin in the treatment of skin and soft tissue infections.
    Chiodo F; Verucchi G; Acuto G
    J Chemother; 1989 Jul; 1(4 Suppl):712-3. PubMed ID: 16312603
    [No Abstract]   [Full Text] [Related]  

  • 24. [Miocamycin in ambulatory dental surgical practice].
    Capuzzi P; Mazzanti F; Balla G; Tani P
    G Stomatol Ortognatodonzia; 1986; 5(3):49-51. PubMed ID: 3499403
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of propolis in the treatment of local suppurative infection].
    Tsarev NI; Petrik EV; Aleksandrova VI
    Vestn Khir Im I I Grek; 1985 May; 134(5):119-22. PubMed ID: 4035908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of the TMS-19-Q.GC tablet on superficial suppurative disease. A comparative double blind study with midecamycin].
    Watanabe S; Kukita A; Miura Y; Tsukinaga I; Tagami H; Tanita Y; Nonami E; Shishiba T; Fujita K; Shigeno Y
    Jpn J Antibiot; 1985 May; 38(5):1331-54. PubMed ID: 3900456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Josamycin in the treatment of ambulatory dental infections].
    Tassinari M; Giannelli G; Palano D; Pastore A; Mincione E; Cantoni E
    Dent Cadmos; 1986 Mar; 54(5):93-4, 97-100. PubMed ID: 3460854
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution].
    Miravalle C; Ardizzi A; Barberis S; Galietti F; Giorgis GE; Oliaro A
    Minerva Med; 1987 May; 78(9):623-6. PubMed ID: 3495753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial prophylaxis for wounds and procedures in the emergency department.
    Moran GJ; Talan DA; Abrahamian FM
    Infect Dis Clin North Am; 2008 Mar; 22(1):117-43, vii. PubMed ID: 18295686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy using 9,3"-di-O-acetyl-midecamycin with beta-lactam antibiotics against Pseudomonas aeruginosa infection.
    Mashimo K; Homma JY; Iki Y; Inatomi K; Kasai T; Kunii O; Shimada K; Tanimoto H; Takigami T; Nishimura Y
    Jpn J Exp Med; 1981 Oct; 51(5):271-85. PubMed ID: 6798249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ambulatory anti-infective therapy. Multicentric studies with cefotaxime treatment of 12,181 patients].
    Pozzi E; Luisetti M; Peona V; Colombo ML
    G Ital Chemioter; 1982; 29(1):21-38. PubMed ID: 6309598
    [No Abstract]   [Full Text] [Related]  

  • 34. Roxithromycin in skin and soft tissue infections.
    Agache P; Amblard P; Moulin G; Barrière H; Texier L; Beylot C; Bergoend H
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():153-6. PubMed ID: 3323167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Josamycin in oral-dental infections].
    Lagarrigue J
    Chir Dent Fr; 1982 May; 52(159):35-8. PubMed ID: 6961989
    [No Abstract]   [Full Text] [Related]  

  • 36. Infections in the elderly: current concepts in management.
    Madhavan T
    Compr Ther; 1994; 20(8):465-70. PubMed ID: 7956104
    [No Abstract]   [Full Text] [Related]  

  • 37. Midecamycin in the treatment of otorhinolaryngological infections.
    Polpathapee S; Na-Nakorn A
    J Med Assoc Thai; 1985 Aug; 68(8):412-4. PubMed ID: 4067459
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
    Imaizumi T; Ishikawa H; Hashimoto I
    J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and bacteriological evaluation of miocamycin in some respiratory tract infections].
    Catania S; Mascellino MT; Fornasiero M; Musso R
    Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):323-5. PubMed ID: 3509889
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetics and tissue distribution of miocamycin].
    Fraschini F; Scaglione F; Cantarella G; Marchi E; Scarpazza P
    Ann Ist Super Sanita; 1987; 23(4):887-90. PubMed ID: 3502552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.